CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2020		$ 1,799	$ (85,086)	$ (83,287)
Beginning balance (in shares) at Dec. 31, 2020	689,929
Stockholders' Deficit
Vesting of restricted common stock (in shares)	27,989
Exercise of stock options		25		25
Exercise of stock options (in shares)	4,473
Equity-based compensation expense		794		794
Net loss			(16,667)	(16,667)
Ending balance at Mar. 31, 2021		2,618	(101,753)	(99,135)
Ending balance (in shares) at Mar. 31, 2021	722,391
Beginning balance at Dec. 31, 2020		1,799	(85,086)	(83,287)
Beginning balance (in shares) at Dec. 31, 2020	689,929
Stockholders' Deficit
Net loss				(56,099)
Ending balance at Sep. 30, 2021		4,730	(141,185)	(136,455)
Ending balance (in shares) at Sep. 30, 2021	778,949
Beginning balance at Mar. 31, 2021		2,618	(101,753)	(99,135)
Beginning balance (in shares) at Mar. 31, 2021	722,391
Stockholders' Deficit
Vesting of restricted common stock (in shares)	26,676
Exercise of stock options		5		5
Exercise of stock options (in shares)	1,034
Equity-based compensation expense		1,002		1,002
Net loss			(23,181)	(23,181)
Ending balance at Jun. 30, 2021		3,625	(124,934)	(121,309)
Ending balance (in shares) at Jun. 30, 2021	750,101
Stockholders' Deficit
Vesting of restricted common stock (in shares)	26,263
Exercise of stock options		14		14
Exercise of stock options (in shares)	2,585
Equity-based compensation expense		1,091		1,091
Net loss			(16,251)	(16,251)
Ending balance at Sep. 30, 2021		4,730	(141,185)	(136,455)
Ending balance (in shares) at Sep. 30, 2021	778,949
Ending balance at Dec. 31, 2021	$ 3	346,312	(160,886)	185,429
Ending balance (in shares) at Dec. 31, 2021	27,358,375
Stockholders' Deficit
Vesting of restricted common stock (in shares)	15,441
Exercise of stock options		16		16
Exercise of stock options (in shares)	2,657
Equity-based compensation expense		2,029		2,029
Net loss			(21,353)	(21,353)
Ending balance at Mar. 31, 2022	$ 3	348,357	(182,239)	166,121
Ending balance (in shares) at Mar. 31, 2022	27,376,473
Beginning balance at Dec. 31, 2021	$ 3	346,312	(160,886)	$ 185,429
Beginning balance (in shares) at Dec. 31, 2021	27,358,375
Stockholders' Deficit
Exercise of stock options (in shares)				2,657
Net loss				$ (65,756)
Ending balance at Sep. 30, 2022	$ 3	352,937	(226,642)	126,298
Ending balance (in shares) at Sep. 30, 2022	27,407,149
Beginning balance at Mar. 31, 2022	$ 3	348,357	(182,239)	166,121
Beginning balance (in shares) at Mar. 31, 2022	27,376,473
Stockholders' Deficit
Vesting of restricted common stock (in shares)	15,361
Equity-based compensation expense		2,709		2,709
Net loss			(24,613)	(24,613)
Ending balance at Jun. 30, 2022	$ 3	351,066	(206,852)	144,217
Ending balance (in shares) at Jun. 30, 2022	27,391,834
Stockholders' Deficit
Vesting of restricted common stock (in shares)	15,315
Equity-based compensation expense		1,871		1,871
Net loss			(19,790)	(19,790)
Ending balance at Sep. 30, 2022	$ 3	$ 352,937	$ (226,642)	$ 126,298
Ending balance (in shares) at Sep. 30, 2022	27,407,149